butylscopolammonium bromide has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, U; Dittler, HJ; Fink, U; Gerhardt, P; Helmberger, H; Herter, B; Schulte, B; Sendler, A | 1 |
| Hof, N; Lehner, K | 1 |
2 other study(ies) available for butylscopolammonium bromide and Esophageal Neoplasms
| Article | Year |
|---|---|
Adenocarcinoma of the gastro-esophageal junction: CT for monitoring during neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Butylscopolammonium Bromide; Chemotherapy, Adjuvant; Contrast Media; Emulsions; Esophageal Neoplasms; Esophagogastric Junction; Esophagoscopy; Fasting; Female; Gastrointestinal Agents; Gastroscopy; Glucagon; Humans; Injections, Intravenous; Male; Middle Aged; Muscarinic Antagonists; Paraffin; Pharmaceutic Aids; Radiography, Interventional; Single-Blind Method; Stomach Neoplasms; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1996 |
[Esophagus carcinoma--progress in staging with thin layer spiral CT?].
Topics: Butylscopolammonium Bromide; Contrast Media; Esophageal Neoplasms; Esophagus; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Tomography, X-Ray Computed | 1998 |